Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Rapid Micro Biosystems (RPID) Revenue (2020 - 2025)

Rapid Micro Biosystems' Revenue history spans 6 years, with the latest figure at $11.3 million for Q4 2025.

  • On a quarterly basis, Revenue rose 37.28% to $11.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $33.6 million, a 19.74% increase, with the full-year FY2025 number at $33.6 million, up 19.74% from a year prior.
  • Revenue hit $11.3 million in Q4 2025 for Rapid Micro Biosystems, up from $7.8 million in the prior quarter.
  • Over the last five years, Revenue for RPID hit a ceiling of $11.3 million in Q4 2025 and a floor of $3.9 million in Q2 2022.
  • Historically, Revenue has averaged $6.2 million across 5 years, with a median of $6.1 million in 2021.
  • Biggest five-year swings in Revenue: surged 136.41% in 2021 and later tumbled 37.03% in 2022.
  • Tracing RPID's Revenue over 5 years: stood at $5.2 million in 2021, then dropped by 16.01% to $4.4 million in 2022, then soared by 44.88% to $6.3 million in 2023, then increased by 29.68% to $8.2 million in 2024, then soared by 37.28% to $11.3 million in 2025.
  • Business Quant data shows Revenue for RPID at $11.3 million in Q4 2025, $7.8 million in Q3 2025, and $7.3 million in Q2 2025.